Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, and QuidelOrtho and Encourages Investors to Contact the Firm
For more information on the Ocugen class action go to: https://bespc.com/cases/OCGN
- For more information on the Ocugen class action go to: https://bespc.com/cases/OCGN
QuidelOrtho provides tests for the detection and diagnosis of various respiratory diseases and other medical conditions. - The Company’s respiratory business has historically been tied to the sale of seasonal flu tests and more recently to COVID-19 detection tests.
- On this news, the price of QuidelOrtho stock dropped $4.85, or more than 10 percent, to close at $42.15 on April 2, 2024.
- For more information on the QuidelOrtho class action go to: https://bespc.com/cases/QDEL